By Lisa Brown

Third Annual Giving Day Today, April 6

April 6th, 2016 in Featured

24-hour fundraising drive: challenges, activities, social media shout-outs

Gift cochair Juliana Zeta Freeman (CAS’16) hopes for a strong senior participation in the 2016 #BUGivingDay 24-hour fundraiser. Photo by Andrew Parlato

Gift cochair Juliana Zeta Freeman (CAS’16) hopes for a strong senior participation in the 2016 #BUGivingDay 24-hour fundraiser. Photo by Andrew Parlato

Today, the Boston University community will come together for the University’s third annual Giving Day, a 24-hour fundraising drive that will benefit the BU Annual Fund. In addition to raising money online, there will be activities across the Charles River and Medical Campuses and a community-wide social media shout-out of favorite things about BU.

Since launching in 2014, Giving Day has raised more than $2.1 million from over 7,954 students, alumni, parents, faculty, staff, and friends of the University. Those funds have been used to support BU’s individual schools and colleges, scholarships, athletics, study-abroad experiences, libraries, the Community Service Center, and sustainability initiatives.

“Giving Day is a chance for everyone in the BU community to come together for 24 hours and celebrate the things they care about at BU,” says Dan Allenby, Development & Alumni Relations assistant vice president for annual giving. “In the first two years of this event, 332 worthy causes at BU received donations on Giving Day. We hope that continues to grow this year as more members of our community choose to give back.”

The day’s goal isn’t just to raise money, but to connect the entire BU community—no matter how far-flung—through school spirit and the common goal of supporting the University’s research, education, athletics, and programs. Terriers are encouraged to support any area of BU they choose with a donation. As in previous years, donors can unlock bonus funds throughout the day by winning challenges sponsored by alumni. Gifts made to schools, colleges, and varsity athletics will also qualify for additional matching funds. Dollars raised for particular causes and by various groups (e.g., school vs school, team vs team, and alumni vs students) are tracked, leaderboard-style, on the Giving Day website.

Challenges offer extra incentive to give

New this year are two challenges sponsored by recent graduates. The first comes from the 2016 Class Gift Committee and encourages current students to support their favorite campus activity. The clubs or organizations that secure the most student donors will win matching funds.

“I’m choosing to give back to BU on Giving Day because the tuition I pay goes to the general BU student body, but my gift goes directly to something specific on campus that I care about,” says 2016 Class Gift cochair Juliana Zeta Freeman (CAS’16). She and her fellow committee members are hoping for a strong senior turnout to take advantage of the matching funds.

The second challenge is sponsored by Hillary Babick (CFA’11), who hopes it will inspire her peers to give. If 100 recent graduates make donations between 1 and 2 p.m. tomorrow, she will give $500 to the Community Service Center, which oversees 14 service programs as well as numerous one-time service projects and events.

“Recent grad giving is really important,” says Babick. “I’ve found that a lot of my peers have great affinity for the University, but that doesn’t necessarily match what we can contribute. I choose to give on Giving Day because it’s all about participation and raising your hand.”

The BU Alumni Association will announce hour-long challenges like Babick’s on its social media accounts throughout the day. They will also be highlighted on the Giving Day website.

On-campus activities

There are several ways to be part of Giving Day in person, as well as online. On the Charles River Campus, from 11 a.m. to 3 p.m. the GSU Link will be Giving Day headquarters. Activities will include a photo booth and appearances by Rhett. Student radio station WTBU deejays will provide the soundtrack for the day, and participating student groups will host informational tables. Multiple giving stations will be set up on the Medical Campus, with opportunities to be featured in photos and posts shared over social media.

Social media activity

Participants can use the hashtag #BUGivingDay on Facebook, Instagram, Twitter, and Vine posts to join in the conversation and to check out what others are saying about Giving Day. You can also follow the day’s activities on the University’s Snapchat account, @bostonu. Participants can tell the BU community why they donated by posting videos, photos, or testimonials using the #IGivetoBU hashtag.

Giving Day ends at midnight EDT tonight, Wednesday, April 6. Donate at Questions about the event? Email, call 800-447-2849, or visit the website.

Watch a video about this year’s Giving Day above.

This BU Today story was written by Lindsay A. Roth.

Medical Campus Employees Receive Service Awards

March 31st, 2016 in Uncategorized

Each year Boston University holds recognition events to honor employees who have reached service milestones in their careers at BU.

A luncheon was held March 31 to honor faculty and staff who have completed 10 and 25 years of service. In total, there were 87 people honored for 25 years and 238 honored for 10-year service milestones.

“Your dedicated service has been and continues to be a key factor in realizing the University’s mission. We are delighted to honor you and, in doing so, to celebrate the diversity of talent and expertise that makes this University great. Your service is the foundation of our institution,” said President Robert A. Brown.

“We are proud to honor these employees who have made a significant career commitment to the Boston University,” said BU Medical Campus Provost and BUSM Dean Karen Antman, MD. “We appreciate your ongoing dedication to the continuing success of the Medical Campus.

Celebrating 10 Years of Service

Edith Ablavsky School of Public Health
Sandhya Agnihotri Alumni Medical Library
David Ananian National Emerging Infectious Diseases Laboratories
Kimberly Avila Henry M. Goldman School of Dental Medicine
Markus Bachschmid School of Medicine
Marco Basta Information Services & Technology
Jennifer Beard School of Public Health
Alexander Bendayan Henry M. Goldman School of Dental Medicine
Shalender Bhasin School of Medicine
Steven Bookless Henry M. Goldman School of Dental Medicine
Lisa Brown School of Medicine
Ci-Di Chen School of Medicine
Clara Chen School of Public Health
Ilia Jorgji Coka School of Medicine
Sharon Coleman School of Public Health
Tasha Coughlin School of Public Health
Yolanda Cuevas Henry M. Goldman School of Dental Medicine
Kathie Davis-Dottin Henry M. Goldman School of Dental Medicine
Richard Dinnocenzo Henry M. Goldman School of Dental Medicine
Melissa Dipetrillo School of Medicine
Gheorghe Doros School of Public Health
Denise Eckstrom School of Medicine
Margaret Errante Dental Health Center
Stephanie Ettinger De Cuba School of Public Health
Alik Farber School of Medicine
Jesuina Fernandes Henry M. Goldman School of Dental Medicine
Anne Fidler School of Public Health
Fausta Freire School of Medicine
Shahnaz Gharib Henry M. Goldman School of Dental Medicine
Avneesh Gupta School of Medicine
Selim Hascelik Alumni Medical Library
Lori Henault School of Medicine
Ronald Iverson School of Medicine
Scharukh Jalisi School of Medicine
Rinat Jonas School of Medicine
Joanne Kayden Dental Health Center
Bruce Larson School of Public Health
Ana Lemus School of Medicine
Karin Leschly School of Medicine
Gang Liu School of Medicine
Donna Magnanti School of Medicine
Keith McDonald BUMC Facilities Management
Raquel McDonald School of Medicine
Hans Meier-Ewert School of Medicine
Asim Mian School of Medicine
Linda Ng School of Medicine
Jingbo Niu School of Medicine
Sheree Norquist Henry M. Goldman School of Dental Medicine
Maria Ober School of Medicine
Mikel Panajoti Public Safety
Christopher Pellegrino Henry M. Goldman School of Dental Medicine
Aeisha Pringle Henry M. Goldman School of Dental Medicine
Fuzhong Qin School of Medicine
John Reilly Henry M. Goldman School of Dental Medicine
Catherine Rich School of Medicine
Linda Rosen Graduate Medical Science
Jennifer E Rosen School of Medicine
Amy Rubin School of Medicine
Kelley Saia School of Medicine
Erdjan Salih Henry M. Goldman School of Dental Medicine
Sepehr Sekhavat School of Medicine
Kimberly Shea School of Public Health
Dhurata Shosho Henry M. Goldman School of Dental Medicine
Elizabeth Stier School of Medicine
Tony Tannoury School of Medicine
Gloria Vachino City Lab
Alexander Walley School of Medicine
Mary Walsh School of Medicine
Jennifer Ward School of Medicine
Rebecca Washburn School of Medicine
Justyna Wells Public Safety
Elizabeth Whitney School of Medicine
Mary Wienke School of Medicine
James Wolff School of Public Health
Weining Zhao Henry M. Goldman School of Dental Medicine

Celebrating 25 Years of Service

Ildiko Akey School of Medicine
Thomas Barber School of Medicine
Willie Barker Public Safety
Edward Bernstein School of Medicine
Pelly Chang Henry M. Goldman School of Dental Medicine
Wendy Cheney Henry M. Goldman School of Dental Medicine
Lora Forman School of Medicine
Haiyan Gong School of Medicine
Joseph Kahn School of Medicine
Vasken Kroshian School of Medicine
Harold Lazar School of Medicine
Birgitta Lehman School of Medicine
Luigi Martiniello Public Safety
Christine Paal School of Public Health
John Palfrey School of Medicine
Hee-Young Park Graduate Medical Science
Nicole Prudent School of Medicine
Richard Rabbett Henry M. Goldman School of Dental Medicine
N. Paul Rosman School of Medicine
Shelley Russek School of Medicine
Florina Tynyanova Medical Library
Eugene Uzogara School of Medicine

Faculty and Students: Submit an Abstract for McCahan Day

March 30th, 2016 in Announcements, Featured, Research

COM McCahan program-cover-1-25-16Last year more than 100 faculty, staff, residents and students attended John McCahan Medical Education Day at the BU Medical Campus. Now is your chance to submit an abstract for a workshop or a poster.

This year the event will be held on Wednesday, May 25 and it will be hosted by the Department of Medical Sciences and Education. The theme of the day will be “Interactive Learning” and the keynote speaker is Dr. Colin Montpetit.

Please visit the McCahan Day website for more information and to submit a workshop proposal or poster abstract; submission deadline is April 8.

Help When Needed: Faculty & Staff Assistance Office

March 30th, 2016 in Featured

Free, confidential counseling for navigating work and life issues

Karen Brouhard (left) and Bonnie Teitleman, both licensed clinical social workers, are counselors at the Faculty & Staff Assistance Office. Photo by Jackie Ricciardi

This is the first in a series about Boston University services available to faculty and staff to help with work-related and personal issues.

BU’s Faculty & Staff Assistance Office (FSAO) provides a quiet, reassuring environment where employees can talk about issues affecting their professional or personal lives. For three decades, the office in the basement of the School of Social Work building on Bay State Road—staffed by licensed clinical social workers—has offered counseling, resources, and referrals to those seeking help with addiction, domestic violence, mental health, relationship, and parenting issues, and managing a work-life balance. Services are free and completely confidential.

“We are experienced behavioral health providers who know and understand the culture here at Boston University,” says Bonnie Teitleman (SSW’83), director of FSAO. “We offer a compassionate, caring environment.”

With locations on both the Charles River and Medical Campuses, the FSAO is available to all full- and part-time employees and their families, providing what’s called a brief treatment model, where people can be seen for up to six sessions. During the initial visit, an employee meets with a counselor to talk about the nature of the issue. “We will brainstorm potential ways to cope with the situation—sometimes that will be a series of brief meetings, where we’ll identify and solve the person’s problem,” Teitleman says. Other times, a person may present with a longer-term problem that requires a referral to a therapist, a family counselor, or another experienced professional in the community. When outside help is required, Teitleman and Karen Brouhard, the FSAO’s other counselor, help to find the right provider.

“If it’s a relationship issue, we might take several sessions to discern if it’s a relationship the person wants to work with, if it’s salvageable,” says Teitleman. “We have couples therapists in the community we could refer them to with their partner for some of that work on repair. If, on the other hand, they’ve decided through several sessions that they either don’t want to stay in the relationship or they don’t know what they want to do, at that point we would consider referring them to another clinician in the community.”

Bonnie Teitleman meeting with a client

Teitleman and Brouhard, both with years of experience in a variety of mental health and medical settings, have seen and dealt with just about every problem imaginable. They routinely help people to navigate workplace issues, from harassment and bullying to a bad performance review. They may serve as a sounding board for a supervisor struggling with an ineffective employee, a faculty member who needs help mediating a difficult relationship with a colleague, a family struggling with the death of a loved one, or a new employee who has relocated to Boston and needs help finding a mental health provider for themselves or a family member.

“People don’t have to have a mental health problem or symptoms to access our services,” says Brouhard. “So often it’s an issue that’s emerged in a relationship or in their personal life, where they need a little extra support, some assistance coping, someone to help them think through an issue.”

FSAO also helps people hoping to enhance their job performance. An employee may want help becoming more assertive, being a better listener, or learning to cope with stress so they can respond thoughtfully in situations, rather than being reactive.

“We’ll work with someone to help figure out how they want to manage their career,” Brouhard says. “We’ll help someone figure out if it’s time for them to move on from a job that’s not a good fit or that has them hitting their heads on the ceiling.” The office maintains a list of career counselors in the Boston area they can refer faculty and staff to as needed.

Often, employees seek out FSAO’s help for problems at home, such as dealing with the emotional fallout from a divorce, finding resources for aging parents, or parenting children with special needs.

The FSAO website provides information and suggestions for dealing with a host of subjects, including stress and anxiety (the number one issue for employees, according to Teitleman), compulsive behaviors, work issues, family challenges, relationships, coping with change, elder care, trauma, anger management, and retirement. There are quizzes that help identify areas where support is needed.

In addition to seeing individuals one-on-one or with family members, FSAO has customized workshops for departments and groups across campus, on topics from strategies for maintaining a healthy work-life balance to mindfulness as a tool for building resilience to how to talk to elderly loved ones about end-of-life issues to how to manage addiction. In times of crisis, the staff is often called upon as first responders, offering grief counseling.

“With a workforce this large, there are going to be deaths, there are going to be tragedies that affect our employees,” says Brouhard. “If there’s been an incident that’s affected an employee, a manager often will contact us to consult about how to support the employee at such a time. That might involve us coming in and meeting with the work group, facilitating the conversation, providing some critical incident debriefing.”

“I often find myself saying to distressed people that organizations per se don’t have a conscience, but the people who work in the organizations do,” says Teitleman. “That’s the part of the organization that we want to represent—the part that wants to see people treated well, treated with respect. One of the things I find most gratifying about our work is to help an employee with a problem this year, and then they come back next year with a different problem. That tells us that we’ve been successful with them, when we see them as repeat customers.”

The Charles River Campus Faculty & Staff Assistance Office is at 270 Bay State Rd. Call 617-353-5381 for an appointment. The FSAO also has a Medical Campus office, in the Solomon Carter Fuller Mental Health Building, 85 East Newton St., eighth floor, Room 818B. Call 617-638-5381 for an appointment.

This is a BU Today article.

Full Professorships for Eight on Medical Campus

March 28th, 2016 in Featured

Faculty from MED, SDM, and SPH promoted

Paul Duprex (right) works with research technician Andrew Acciardo inside the NEIDL virology lab. Photo by Jackie Ricciardi

Paul Duprex, originally from Northern Ireland, specializes in the genetics of viruses. Haiyan Gong (GRS’91), a native of China, has spent nearly three decades studying a single system in the eye and its relation to glaucoma, a leading cause of blindness worldwide. The two are among eight BU Medical Campus faculty recently promoted to full professor.

“These promotions signify a major milestone in our faculty’s careers,” says Karen Antman, dean of the School of Medicine and provost of the Medical Campus. “Achieving the rank of professor recognizes their outstanding contributions plus their national and international reputations.”

Duprex, a MED professor of microbiology and director of the cell and tissue imaging core at BU’s National Emerging Infectious Diseases Laboratories (NEIDL), studies the pathogenesis and spread of human and animal viruses, and has worked on the molecular biology of paramyxoviruses for more than 20 years. These include measles, mumps, and canine distemper viruses, which require Biosafety Level 2 containment. As a molecular virologist, he uses genetic techniques to manipulate the genomes of these viruses and make them glow green, red, or blue when they infect a cell. This allows him to illuminate diseases and track the spread of viruses inside and between hosts.

One side of his work is mapping the parts of the genes that build viruses and cause disease. The flip side is trying to identify changes in the genes that can transform viruses from killers into vaccines.

Duprex grew up in Lurgan, a small market town outside Belfast. He takes pride in his roots, but the self-described “child of the Troubles” grew up thinking a lot about the inequities of the world, and is a proponent the idea of global health. He arrived in Massachusetts a decade ago on a Bill and Melinda Gates Foundation Grand Challenges in Global Health grant to work at Johnson & Johnson as principal scientist on a project to make heat-stable vaccines.

“Millions and millions and millions of people are alive today because of vaccines,” Duprex says, “and they’re not just the preserve of us in the developed world—they really have been sent to all corners of the developing world, and that’s brilliant.”

Duprex earned a BSc in biochemistry and genetics at the Pirbright Institute and Queen’s University Belfast, and a PhD in molecular virology from Queen’s University, where he became a senior lecturer before coming to BU in 2010.

A special focus of his team’s research is understanding what allows an animal virus to jump to a human population or prevents that from happening. “You need to pick apart these processes slowly and systematically,” he says. “Here’s the virus and here’s a human cell. Can it get in? Can it replicate? Can it get out to spread infection? And can it spread from this host to that host? Understand all of those stages, and you begin to identify the weak points, and it’s potentially possible to stop it.”

Haiyan Gong working at the electronic microscope with research fellow Lihua Lilian Gong. Photo by Cydney Scott

Gong, a MED professor of ophthalmology and of anatomy and neurobiology, arrived at BU in 1986 with a compelling backstory. Raised in China during the Cultural Revolution, she attended nursing school and worked as a nurse in the ophthalmology department of a city hospital. When China began to relax its social strictures, she earned an MD at Jiangxi Medical College and received additional training in ophthalmology. Then the real drama began.

“I went to Tibet as a volunteer after graduation,” she says. “At the time, Tibet didn’t have a train, so we took a bus, a whole week over the mountains to get to Lhasa. I was assigned to Lhasa City People’s Hospital. I told the president of the hospital that I had additional training in ophthalmology, and wished to become an ophthalmologist. But I was told, ‘We need a surgeon right now.’

“The first day I reported to the surgery department they told me, ‘Two surgeries today,’ so I went to hide in the dressing room to look at the textbook to review how to perform the operations,” she says, shaking her head. “But you learn a lot and quickly in that kind of environment.”

With an MS in ophthalmology from Peking Union Medical College, Gong landed a research fellowship at West Virginia University before coming to BU, where she earned a PhD in anatomy and became interested in studying the aqueous outflow system, which drains aqueous humor in the eye to maintain needed pressure and provide nutrition to the eye. Its blockage or constriction causes elevated intraocular pressure, a primary risk factor for the development and progression of primary open-angle glaucoma.

The technique she’s developed to evaluate the structure and function of the system has helped in the testing of new drugs and surgical devices. Her work has been funded by numerous National Institutes of Health (NIH) grants.

“I think we’ve answered some questions, but then new questions emerged,” she says. “Over time you learn to ask more clinical relevant research questions.”

Besides Paul Duprex and Haiyan Gong, the Medical Campus faculty promoted to full professor are:

Pushkar Mehra, Goldman School of Dental Medicine professor of oral and maxillofacial surgery

Mehra specializes in the surgical treatment of obstructive sleep apnea, maxillofacial pathology, nerve repair, and complex functional and aesthetic facial reconstruction. He is department chair and associate dean for hospital affairs, overseeing the clinical training of postdoctoral residents at Boston Medical Center. A fellow of the American Association of Oral and Maxillofacial Surgeons and a Massachusetts delegate to the association, Mehra also serves on the Examination Committee of the American Board of Oral and Maxillofacial Surgery.

Rutao Cui, MED professor of pharmacology and experimental therapeutics and of dermatology

Cui’s research targets cancer biology, focusing both on the molecular basis of melanoma development and potential treatments. He is director of the MED Laboratory of Melanoma Research in Cancer Pharmacology. He has received funding from the NIH, the US Department of Defense (DOD), and private foundations, and now has grants from the National Cancer Institute, the DOD, and the Melanoma Research Foundation. His recent research has focused in part on the correlation between having red hair and developing melanoma.

Noyan Gokce, MED professor of medicine (cardiology)

Gokce’s research is focused on the study and treatment of obesity-related cardiovascular disease and the effect of adipose tissue on vascular biology. He is Boston Medical Center’s director of echocardiography, chairs the NIH Section on Translational Research in Diabetes and Obesity, and has been elected to the American Society for Clinical Investigation. He is a past recipient of an NIH Research Career Development Award and has twice received the Cardiology Section’s Excellence in Clinical Teaching Award.

Marc Lenburg, MED professor of medicine and of pathology and laboratory medicine and College of Engineering professor of bioinformatics

Lenburg, whose primary appointment is at MED, works with genomic technology and translational bioinformatics to detect and treat lung cancer, emphysema, and chronic obstructive pulmonary disease. He has developed computational methods for a commercially available gene-expression biomarker used in the clinical care of patients with suspected lung cancer and has received several NIH grants. He is the deputy director of BU’s Clinical & Translational Science Institute bioinformatics core.

Pieter Noordzij, MED professor of otolaryngology–head and neck surgery

Noordzij’s research is centered on medical and surgical management of disorders affecting the larynx and the thyroid gland, including voice and swallowing disorders. His work includes care of the professional voice and development of new techniques to treat vocal fold paralysis. His research on proton pump inhibitor therapy for laryngeal reflux is considered a landmark development in the treatment of nonspecific laryngitis. He is a past recipient of the Charles Vaughan Excellence in Teaching Award and the Didactic Teacher of the Year Award, both given by otolaryngology residents to a single faculty member

Lauren Wise, School of Public Health professor of epidemiology

Wise’s work in reproductive and perinatal epidemiology focuses on the genetic and environmental determinants of uterine fibroids in African American women, as well as risk factors for delayed conception and adverse pregnancy outcomes. She is principal investigator of the Pregnancy Study Online (PRESTO), a web-based research study of time-to-pregnancy and birth outcomes being conducted in North America and Denmark and funded by the NIH. The study examines whether lifestyle factors such as diet, exercise, and medication use have an impact on fertility and pregnancy outcomes. She is a recipient of the ASPH/Pfizer Young Investigator’s Award for Distinguished Research in Public Health, given by the Association of the Schools of Public Health.

This BU Today story was written by Joel Brown.

Medical Campus Experts Gather to Confer about Zika

March 25th, 2016 in Featured, Research

NEIDL acquires sample of virus for further study

Donald Thea, director of the BU Center for Global Health & Development, spoke on the public health aspects of the Zika virus at a BUMC Provost Seminar March 22. “We are at the cusp of a really interesting part of the Zika virus investigation,” Thea said. Photo by Cydney Scott

Donald Thea, director of the BU Center for Global Health & Development, spoke on the public health aspects of the Zika virus at a BUMC Provost Seminar March 22. “We are at the cusp of a really interesting part of the Zika virus investigation,” Thea said. Photo by Cydney Scott

After weeks of BU researchers trying to procure a sample of Zika virus, the pathogen linked to microcephaly and other neurological syndromes, the vial finally arrived at BU’s National Emerging Infectious Diseases Laboratories (NEIDL) on March 22. NEIDL director Ronald B. Corley, a School of Medicine professor and chair of microbiology, announced the acquisition that day at a BUMC Provost Research Seminar. Zika, like dengue, mumps, and measles, is a Biosafety Level 2 pathogen, defined by the Centers for Disease Control and Prevention (CDC) as an agent that poses “moderate hazards to personnel and the environment.”

The sample was of the strain originally isolated in 1947, and it will allow scientists to grow and propagate the virus for study. The 1947 strain is the precursor to the virus causing the current outbreaks in South America and the Caribbean. Because samples of the modern virus are proving difficult to obtain, scientists at NEIDL will begin their work using the 1947 isolate while using published genetic data to make a clone of the modern Zika strain.

“There’s a real need for us to be doing research on this virus. It’s been seen in Boston and will be again,” said John Connor, a MED associate professor of microbiology and a NEIDL researcher, who acquired the Zika sample from the Biodefense and Emerging Infections Research Resources Repository, a supply house for scientists studying infectious diseases. “Having the virus will allow us to ask important questions, like: what is driving the pathogenesis? How is the virus getting across the placental barrier? What is its replication like in mosquitos?” Connor said. “Without understanding the virus, it’s hard to know how to block it.”

Karen H. Antman, dean of MED and provost of the Medical Campus, began planning the Zika workshop about six weeks ago, when she became aware that people from BU’s medical, dental, and public health schools were all talking about the virus, but not necessarily collaborating. “It’s a rapidly emerging field—we want everyone doing research on this in the same room,” says Antman. “Clinical people have blood specimens, lab people have techniques. We wanted them all talking to each other.”

Zika grabbed the world’s attention in fall 2015 when scientists in Brazil began to suspect a connection between the virus and microcephaly—babies born with small heads and neurological deficits—and also Zika’s possible link to other neurological syndromes like Guillain-Barré. Since January 1, 2007, 59 countries and territories have reported transmission of Zika virus, according to the World Health Organization (WHO), and on February 1, 2016, the WHO declared the cluster of microcephaly cases and other neurological disorders a health emergency. So far, 258 cases have been reported in the United States, all introduced from other countries.

The Aedes aegypti mosquito, the leading culprit in the spread of Zika virus. By James Gathany, CDC, via Wikimedia Commons

The Aedes aegypti mosquito, the leading culprit in the spread of Zika virus. By James Gathany, CDC, via Wikimedia Commons

The Research Seminar, which included updates from virologists, epidemiologists, and physicians, revealed what scientists have learned about the virus since the 2015 outbreak in Brazil and how many questions remain.

“Zika is difficult to diagnose; the clinical symptoms are really vague,” Robin Ingalls, a MED associate professor of medicine and microbiology, said during her clinical overview of Zika. Ingalls noted that an estimated 80 percent of people infected with Zika show no symptoms at all. Most people who get sick have a red, pimply rash that Ingalls called “very subtle,” along with other symptoms—like fever, headache, fatigue, and malaise—that overlap with dengue fever and chikungunya, making the disease even more difficult to diagnose.

Lab tests “don’t really make it much easier,” she said. “While we can detect virus in the blood, it is only there for about a week after infection.” After the first week, physicians can order blood tests that measure antibodies specific to Zika. Laboratories are reporting a backlog in these tests, however, with results taking as long as six weeks. Also, the tests can be difficult to interpret because of cross-reactions with similar viruses, like dengue, the patient may have been exposed to.

Many questions about transmission, especially from mother to fetus, remain unanswered, Ingalls said. “How can Zika evade the immune response of placenta? What is the critical time for exposure of the fetus? Is there something unique about Brazil that is increasing the risk of microcephaly?” she asked. “We’re just seeing the tip of the iceberg, and we don’t know what the long-term consequences of infection will be.”

“It appears pretty convincing that Zika is linked to microcephaly,” said Donald M. Thea, a School of Public Health professor of global health and director of the BU Center for Global Health & Development, who spoke on the public health aspects of Zika. “From an epidemiological perspective, the question is, how high is the risk?”

Much of Thea’s talk focused on what scientists know about the transmission of Zika from mosquitos to humans, and from one human to another. He noted that scientists have isolated the virus from 10 species of Aedes mosquito, and from several other mosquito families as well. While Aedes aegypti is the best known, he said, Aedes albopictus—introduced into the United States in 1985—is the most worrisome because of its hardiness and wider range. “If efficient transmission is limited to Aedes aegypti, then the virus shouldn’t get beyond Texas and the southeastern United States,” areas with warm, moist air where that mosquito can thrive, he said. But if Aedes albopictus can spread the disease just as well, larger areas of the world may be exposed.

BU’s NEIDL received a sample of Zika earlier this week, which will allow scientists to grow and propagate the virus for study. Photo by Cydney Scott

BU’s NEIDL received a sample of Zika earlier this week, which will allow scientists to grow and propagate the virus for study. Photo by Cydney Scott

Thea also explained what scientists currently know about human-to-human transmission. They have found that patients carry low levels of Zika virus in their blood after symptoms begin, but higher levels of the virus in urine, saliva, and semen for a longer time. (Scientists have also found Zika virus in cerebral spinal fluid and in breast milk.) Thea said that the risk of transmission through semen is especially worrisome. “The amount of virus in semen is very high,” he said, noting that the viral count in semen can be 100,000 times higher than that in blood, and that scientists have measured Zika virus in semen as late as 62 days after infection. “A patient’s semen contains virus before the onset of symptoms, but we’re not sure how long the virus remains infectious. We are at the cusp of a really interesting part of the Zika virus investigation.”

Also speaking at the seminar were Davidson Hamer, Athanasios I. Zavras, and Rachel Fearns. Hamer, an SPH professor of global health, explained how the GeoSentinel Network—a clinic-based global surveillance system that focuses on travelers, immigrants, and refugees—allows scientists to detect new infections and disease patterns, all with lab-confirmed diagnoses. He expects to publish preliminary GeoSentinel Network findings on Zika in the coming months. Zavras, a School of Dental Medicine professor and chair of pediatric dentistry, discussed the detection—and possible transmission—of Zika virus through saliva. Fearns, a MED associate professor of microbiology, described mutations in the Zika genome that may be helping the virus replicate, and spread among people, more efficiently.

“Up until about four years ago, proposing to study Zika was a dead end for funding. It wasn’t very prevalent,” Connor said during a discussion panel at the end of the seminar. “It’s only the recent rapid spread and new adverse outcomes associated with infection that have made research to understand this virus a high priority.”

This BU Today story was written by Barbara Moran.  She can be reached at

April 7 Symposium on Preventing Breast Cancer

March 18th, 2016 in Featured

COM investing_preventionPlease join us to change up the conversation about breast cancer. Let’s talk prevention and get in front of breast cancer by focusing more research dollars on identifying what is actually causing it. NPR’s Tom Ashbrook will moderate a panel discussion on shifting priorities toward comprehensive breast cancer prevention with Boston’s leaders in public health and breast cancer research. The event is presented by the Art beCAUSE Breast Cancer Foundation and showcases members of their research consortium from Boston University and Tufts University. All proceeds will directly benefit the Art beCAUSE Breast Cancer Foundation breast cancer consortium labs at BU and Tufts.

Thursday, April 7
5:30-8 p.m.
Charles River Campus, 1 Silber Way, Trustee Ballroom

More information at

New Approach Urged in Dealing with Opioid Epidemic

March 18th, 2016 in Featured

At SPH event, local police chiefs say care, not jail, needed

Gloucester police chief Leonard Campanello (left) and Arlington police chief Frederick Ryan speaking at Wednesday’s SPH seminar on the current opioid epidemic. Photo by Cydney Scott

Gloucester police chief Leonard Campanello (left) and Arlington police chief Frederick Ryan speaking at Wednesday’s SPH seminar on the current opioid epidemic. Photo by Cydney Scott

Last summer, Arlington, Mass., chief of police Frederick Ryan was briefed on a plan to arrest a major heroin supplier. “I asked some very simple questions,” he recalled. “Do we know the identities of those buying their heroin from this dealer? The answer was yes.

“The follow-up question was, what are we doing to get these people services?” he said. “The answer was: nothing.”

Ryan realized his department was about to create a public health crisis by suddenly leaving a known population of addicted people without their supply. This, he explained, was when he knew his police department needed to try a new approach.

He discussed that shift in thinking at Wednesday’s School of Public Health seminar The Opioid Epidemic: Why Cops Are Sending People with Addiction to Treatment Instead of Jail, the latest in the Dean’s Seminar Series on Contemporary Issues in Public Health.

Ryan joined another Massachusetts police chief, Leonard Campanello (MET’05), of Gloucester, whose department launched the Gloucester Angel Initiative last June. The program approaches addiction as a disease instead of a crime, and has influenced the Arlington police department and dozens of others. As well as garnering national headlines, it was the subject of a CBS 60 Minutes segment in December 2015.

Soon after, Campanello also founded the Police Assisted Addiction and Recovery Initiative to support the Gloucester program and others like it.

With 88 police departments in 22 states now taking similar approaches, Campanello and Ryan “are the leaders of a rapidly growing movement,” said David Rosenbloom, an SPH professor and interim chair of health law, policy, and management, as he introduced the two.

Since the Angel Initiative began, Rosenbloom and colleagues from SPH and the School of Medicine have been working with the Gloucester department, monitoring the program to see if—and how well—it really works.

Rosenbloom began the seminar by handing the microphone off to colleague Davida Schiff (MED’12), a MED instructor and general pediatrics fellow, to present their research findings: from June 1, 2015, to February 15, 2016, 352 people walked into the Gloucester police department asking for treatment. They came from all over the state, and 80 percent had been in treatment before.

The BU researchers have begun following up with past participants in the program, said Schiff, adding that out of the 47 contacted so far, 35 (or 74 percent) are not currently using opioids. “The numbers don’t do it justice,” Schiff cautioned. “The stories of their time through their treatment, the arc of their treatment, with relapse, with struggles to stay clean, is more telling.”

With that in mind, Rosenbloom, Campanello, and Ryan talked about the seminar’s central question: Why would, or should, police departments take on this role in the face of the growing opioid epidemic?

For Campanello, the new approach came from listening to the community he had sworn to serve. “What the community was saying was, ‘We don’t want you arresting people with this disease anymore if you don’t have to.’ Seeing death in large numbers led to this change.”

Social media proved an effective way to communicate the department’s new approach. Campanello shared the plan on Facebook: “Any addict who walks into the police station with the remainder of their drug equipment (needles, etc.) or drugs and asks for help will NOT be charged. Instead we will walk them through the system toward detox and recovery.”

That post soon had 2.5 million hits and was shared 30,000 times in every state and in 61 countries. “When you have Uzbekistan reading the Facebook post of a little North Shore city,” Campanello told the audience, “you get a very, very clear picture of how important this issue is to so many people.”

Soon after, the Arlington police department began outreach to people known to be addicted to opioids. The department had a clinician available to help create treatment plans for them and their families.

The Gloucester and Arlington models are now being adopted around the country.

What makes these approaches different from earlier efforts to get people into treatment within the court system, Campanello said, has to do with stigma. “We’re very anticoercion, anti-incentive, for this disease,” he explained. If even the threat of losing child custody doesn’t work, he said, “how is a charge of possession of an illegal substance going to incentivize someone to give up their disease?”

Stigma is the major challenge here, Ryan concurred, even when it comes to implementing these kinds of programs. He described how for decades police have offered not to charge a drug user if they identified their dealer. “That’s discretion,” he said. “We now apply that very same discretion, ‘You go into treatment and I won’t charge you with a crime,’ and prosecutors are saying, ‘I’m not so sure you have the authority.’”

The other major challenge in dealing with the opioid epidemic, both agreed, is a broader system that is full of holes. “What is so cockamamy,” Rosenbloom asked, “so opaque, about getting help for the disease of addiction that people are flocking to police stations, where they could be arrested?”

Ryan’s answer: “We’re now dispatching a clinician to an overdose in the ER.” His department has seen people brought into the emergency room after overdosing, released, and then fatally overdosing just hours later, he said.

Police, as newcomers to the treatment field, are able to bring a level of optimism and creativity to the problem, Campanello added, along with the clout to help move someone through a complex and confusing system. “We ask very three-year-old-like questions,” he said, “which always begin with, ‘Why?’”

Throughout the event, both police chiefs returned again and again to the idea at the heart of their programs: police should serve their communities. With public opinion of police far less positive in recent years, “it remains the police department’s responsibility to rebuild that trust,” Campanello said.

“There’s no achievement in this whatsoever,” he added. “This is a responsibility. This is what we’re supposed to be doing. We’re supposed to be helping people, especially people with a disease, and if that means thinking outside the box, then that too is a responsibility.”

This BU Today story was written by Michelle Samuels.

BU-CTSI Translational Research Symposium, March 28

March 16th, 2016 in Featured, Research

Boston University Clinical and Translational Science Institute (BU-CTSI)
Fifth Annual Translational Research Symposium
In Memory of David C. Seldin, MD, PhD (1957-2015)

Monday, March 28

Charles River Campus , 775 Commonwealth Ave.,
George Sherman Union, Metcalf Hall

Keynote Speakers

Jeffrey W. Kelly, PhD
Lita Annenberg Hazen Professor of Chemistry
Chairman, Department of Molecular and Experimental Medicine
The Scripps Research Institute

Robert A. Stern, PhD
Professor of Neurology, Neurosurgery and Anatomy & Neurobiology
Director, Clinical Core, Alzheimer’s Disease and CTE Center
Boston University School of Medicine

Ann C. McKee, MD
Professor of Neurology & Pathology
Director, Neuropathology Core, Alzheimer’s Disease Center
Boston University School of Medicine

More information including a detailed agenda and registration

Questions? Contact:

Sponsored by: The Boston University Clinical and Translational Science Institute

The Politics of Access: The Impact of U.S. Government Policies on Pharmaceutical Markets and Public Health

March 16th, 2016 in Featured

Join Boston University School of Public Health students, colleagues, alumni, and affiliates for the BUSPH Pharmaceuticals Program’s 5th Annual Symposium,

The Politics of Access: The Impact of U.S. Government Policies on Pharmaceutical Markets and Public Health

The event will include a panel of professionals from across the board who are making an impact in the field of pharmaceutical access. An alumni luncheon before the program and concluding reception will provide attendees with the chance to reconnect, network, and learn from one another.

RSVP for the event via Eventbrite by 5 p.m. Friday, March 18. Professional Dress requested for all attendees. 

Keynote Address
BU Alumnus, Dr. Howard Koh
Former U.S. Assistant Secretary for Health, U.S. Department of Health and Human Services;
Harvey V. Fineberg Professor of the Practice of Public Health Leadership, Harvard T. H. Chan School of Public Health and Harvard Kennedy School;
Former Commissioner of Public Health for the Commonwealth of Massachusetts

Panel includes

  • Robert Coughlin, President, MassBio
  • Pamela Gavin, COO, National Organization of Rare Disorders
  • Dr. David Jones, Assistant Professor, BU School of Public Health
  • Lora Pellegrini, President and CEO, Massachusetts Association of Health Plans
  • David Seltz, Executive Director, Massachusetts Health Policy Commission

Moderated by Dr. Susan Windham-Bannister, former President and CEO of Mass Life Sciences Center

For more information on each of our panelists, please visit the Pharmaceuticals Program website.  

Date: Friday, March 25, 2016
Time: Program 1- 5 p.m.
Networking reception 5- 6 p.m.
Location: BUSM Instructional Building, Hiebert Lounge